DLL3 targeting Radio-DARPin MP0712 to enter first-in-human study in 2025, pending regulatory clearanceStrategic partnership with Orano Med on Radio-DARPins now expanded to ten programsMP0533 Phase 1/2 ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...